Fig. 5From: miR-124 targets GATA6 to suppress cholangiocarcinoma cell invasion and metastasisExpression of miR-124 affected overall survival (a) and recurrence (b) in 57 CCA patients following surgical resection, determined by Kaplan–Meier analysisBack to article page